Berkowitz CL, Mosconi L, Rahman A, Scheyer O, Hristov H, Isaacson RS.
2018.
Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.. J Prev Alzheimers Dis. 5(4):245-252.
Isaacson RS, Ganzer CA, Hristov H, Hackett K, Caesar E, Cohen R, Kachko R, Meléndez-Cabrero J, Rahman A, Scheyer O et al..
2018.
The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.. Alzheimers Dement. 14(12):1663-1673.
Al-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H.
2018.
Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation.. J Stroke Cerebrovasc Dis. 27(4):839-844.
Kaloostian SW, Vartanian TK, Ordookhanian C, Vartanian T, Kaloostian PE.
2018.
Concomittant fibrous dysplasia with aneurysmal bone cyst formation within the skull, humerus and rib.. J Surg Case Rep. 2018(7):rjy180.
Khazanova D, Safdieh JE.
2018.
Continuing Medical Education in Neurology.. Semin Neurol. 38(4):479-485.
Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BWeinstock, Aaen G, Tillema J-M, Mar S, Hart J et al..
2018.
Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis.. J Neurol Neurosurg Psychiatry. 89(1):28-33.
Safdieh JE, Quick AD, Korb PJ, Torres-Russotto D, Gable KL, Rock M, Cahill C, Soni M.
2018.
A dozen years of evolution of neurology clerkships in the United States: Looking up.. Neurology. 91(15):e1440-e1447.
Merkler AE, Diaz I, Wu X, Murthy SB, Gialdini G, Navi BB, Yaghi S, Weinsaft JW, Okin PM, Safford MM et al..
2018.
Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction.. J Am Heart Assoc. 7(22):e010782.
Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, R Brinton D, Mosconi L.
2018.
Female Sex and Alzheimer's Risk: The Menopause Connection.. J Prev Alzheimers Dis. 5(4):225-230.
Schaefer SM, Dominguez M, Moeller JJ.
2018.
The Future of the Lecture in Neurology Education.. Semin Neurol. 38(4):418-427.
Mosconi L, Brinton RDiaz.
2018.
How would we combat menopause as an Alzheimer's risk factor? Expert Rev Neurother. 18(9):689-691.
Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS.
2018.
Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.. Mult Scler. 24(4):540-542.
Wilcox JA, Ramakrishna R, Magge R.
2018.
Immunotherapy in Glioblastoma.. World Neurosurg. 116:518-528.
Salas RMarie E, Strowd RE, Ali I, Soni M, Schneider L, Safdieh J, Vaughn BV, Avidan AY, Jeffery JB, Gamaldo CE.
2018.
Incorporating sleep medicine content into medical school through neuroscience core curricula.. Neurology. 91(13):597-610.
Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HWebb, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RDiaz.
2018.
Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.. PLoS One. 13(12):e0207885.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.
2018.
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.